共 101 条
[1]
Minicozzi P(2018)Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates Cancer Epidemiol 55 52-60
[2]
Cassetti T(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30
[3]
Vener C(2018)Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Lancet 391 1023-1075
[4]
Sant M(2017)Metastatic pancreatic cancer: American society of clinical oncology clinical practice guideline summary J Oncol Pract 13 261-264
[5]
Siegel RL(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 1817-1825
[6]
Miller KD(2013)Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial J Clin Oncol 31 23-29
[7]
Jemal A(2013)Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 1691-1703
[8]
Allemani C(2017)Patterns of chemotherapy use in a U.S.-based cohort of patients with metastatic pancreatic cancer Oncologist 22 925-933
[9]
Matsuda T(2019)Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe Pancreatology 19 97-104
[10]
Di Carlo V(2020)Some unanswered questions about older adults with metastatic pancreatic cancer J Geriatr Oncol 11 1032-1033